These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7470372)

  • 41. Pathophysiological and disease-induced changes in drug distribution volume: pharmacokinetic implications.
    Klotz U
    Clin Pharmacokinet; 1976; 1(3):204-18. PubMed ID: 797498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug kinetics in pregnancy.
    Krauer B; Krauer F
    Clin Pharmacokinet; 1977; 2(3):167-81. PubMed ID: 328205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid.
    Miners JO
    Clin Pharmacokinet; 1989 Nov; 17(5):327-44. PubMed ID: 2573442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic model of presystemic metabolism.
    Colburn WA; Gibaldi M
    Drug Metab Dispos; 1978; 6(2):193-6. PubMed ID: 26536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites.
    Patel M; Taskar KS; Zamek-Gliszczynski MJ
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S23-39. PubMed ID: 27385177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modelling of drug disposition kinetics in in vitro intestinal absorption cell models.
    Heikkinen AT; Korjamo T; Mönkkönen J
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):180-8. PubMed ID: 20030630
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new model-independent physiological approach to study hepatic drug clearance and its applications.
    Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disease-induced modifications of drug pharmacokinetics.
    Barre J; Houin G; Brunner F; Bree F; Tillement JP
    Int J Clin Pharmacol Res; 1983; 3(4):215-26. PubMed ID: 6381335
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic changes in critical illness.
    Boucher BA; Wood GC; Swanson JM
    Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential kinetics of phenytoin in elderly patients.
    Bachmann KA; Belloto RJ
    Drugs Aging; 1999 Sep; 15(3):235-50. PubMed ID: 10503815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protein binding and kinetics of drugs in liver diseases.
    Blaschke TF
    Clin Pharmacokinet; 1977; 2(1):32-44. PubMed ID: 322909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of aspirin on salivary and serum phenytoin kinetics in healthy subjects.
    Paxton JW
    Clin Pharmacol Ther; 1980 Feb; 27(2):170-8. PubMed ID: 7353335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Projecting ADME Behavior and Drug-Drug Interactions in Early Discovery and Development: Application of the Extended Clearance Classification System.
    El-Kattan AF; Varma MV; Steyn SJ; Scott DO; Maurer TS; Bergman A
    Pharm Res; 2016 Dec; 33(12):3021-3030. PubMed ID: 27620173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mean residence time of drugs administered non-instantaneously and undergoing linear tissue distribution and reversible metabolism and linear or non-linear elimination from the central compartment.
    Cheng H
    Biopharm Drug Dispos; 1995 May; 16(4):259-67. PubMed ID: 7548775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Computer simulations of bioequivalence trials: selection of design and analyte in BCS drugs with first-pass hepatic metabolism: linear kinetics (I).
    Fernández-Teruel C; Nalda Molina R; González-Alvarez I; Navarro-Fontestad C; García-Arieta A; Casabó VG; Bermejo M
    Eur J Pharm Sci; 2009 Jan; 36(1):137-46. PubMed ID: 19028574
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma and tissue protein binding of drugs in pharmacokinetics.
    Jusko WJ; Gretch M
    Drug Metab Rev; 1976; 5(1):43-140. PubMed ID: 829788
    [No Abstract]   [Full Text] [Related]  

  • 58. Modeling drug absorption from enteric-coated granules.
    Dedík L; Durisová M
    Methods Find Exp Clin Pharmacol; 2001 Jun; 23(5):213-7. PubMed ID: 11712638
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interactions and non-interactions with ranitidine.
    Kirch W; Hoensch H; Janisch HD
    Clin Pharmacokinet; 1984; 9(6):493-510. PubMed ID: 6096071
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protein binding displacement interactions and their clinical importance.
    McElnay JC; D'Arcy PF
    Drugs; 1983 May; 25(5):495-513. PubMed ID: 6345130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.